FOXXW vs OGN · rev $65.9M vs P/E 3.4, rev $3.02B
Foxx Development Holdings Inc. (FOXXW) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Foxx Development Holdings Inc. (FOXXW) common stock listed on NASDAQ.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported FOXXW revenue for 2025-06-30 was $65.9M. Net income was -$9.0M. Revenue was up 1941.8% from 2024-06-30 to 2025-06-30. FOXXW currently screens at market cap $0.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
FOXXW currently screens at market cap $0. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the FOXXW and OGN stock pages for the full models.
Not investment advice.